Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.

Casasnovas, R O; Slimane, F K; Garand, R; Faure, G C; Campos, L; Deneys, V; Bernier, M; Falkenrodt, A; Lecalvez, G; Maynadié, M; Béné, M C

Casasnovas, R O; Slimane, F K; Garand, R; Faure, G C; Campos, L; Deneys, V; Bernier, M; Falkenrodt, A; Lecalvez, G; Maynadié, M; Béné, M C.

Affiliation

Casasnovas RO; Hématologie Clinique, CHU Dijon, France.

Leukemia ; 17(3): 515-27, 2003 Mar.

Article in En | MEDLINE | ID: mdl-12646939

Subject(s)

Leukemia, Myeloid, Acute/classification; Leukemia, Myeloid, Acute/immunology; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD/analysis; Child; Child, Preschool; Cluster Analysis; Cohort Studies; Female; HLA-DR Antigens/analysis; Humans; Immunophenotyping; Leukemia, Myeloid, Acute/pathology; Male; Middle Aged; Prognosis; Survival Analysis; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Year: 2003 Document type: Article

Search on Google

XML

PubMed Links